Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET
Company Participants
g – Corporate Participant
e – Corporate Participant
Farrell Simon – Chief Commercial Officer
James V. Cassella – Chief Development Officer
Jennifer L. Good – Co-Founder, CEO, President & Director
Lisa Delfini – Chief Financial Officer
Conference Call Participants
Alexa Rose Deemer – Cantor Fitzgerald & Co., Research Division
Annabel Eva Samimy – Stifel, Nicolaus & Company, Incorporated, Research Division
Brandon Richard Folkes – H.C. Wainwright & Co, LLC, Research Division
Debanjana Chatterjee – JonesTrading Institutional Services, LLC, Research Division
Faisal Ali Khurshid – Leerink Partners LLC, Research Division
Jason Dorr – Oppenheimer & Co. Inc., Research Division
Kaveri Pohlman – Clear Street LLC
Mayank Mamtani – B. Riley Securities, Inc., Research Division
Ryan Phillip Deschner – Raymond James & Associates, Inc., Research Division
Serge D. Belanger – Needham & Company, LLC, Research Division
Operator
Good afternoon, and welcome to the Trevi Therapeutics Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Various remarks that management makes during this conference call about the company’s future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995.
Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of the company’s most recent quarterly report on Form 10-Q, which the company filed with the SEC this afternoon.
In addition, any forward-looking statements represent the company’s views only as of today and should not be relied upon as representing the company’s views as of any subsequent date. While the company may elect to update these forward-looking statements at some point in the future, the
